Research progress in systemic lupus erythematosus from 2021 to 2022.
10.7499/j.issn.1008-8830.2302150
- Author:
Yong-Zhen LI
1
;
Xiao-Chuan WU
1
Author Information
1. Department of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410000, China.
- Publication Type:Journal Article
- Keywords:
Diagnosis;
Pathogenesis;
Systemic lupus erythematosus;
Treatment
- MeSH:
Humans;
Lupus Erythematosus, Systemic/therapy*;
Proteomics
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(8):785-790
- CountryChina
- Language:Chinese
-
Abstract:
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems, presenting a complex and diverse clinical manifestation. The heterogeneous treatment response and prognosis of SLE pose significant challenges to its diagnosis, classification, and homogeneous treatment. The emergence of new technologies and fields, such as synthetic biology, genomics, and proteomics, has contributed to a deeper exploration of the pathogenesis and biomarkers of SLE, facilitating precision diagnosis and treatment. This review summarizes the latest research data and achievements in SLE for the years 2021-2022, providing an overview and summary of relevant studies conducted in the past two years.
